CytoSen Therapeutics appoints Reata Pharmaceuticals CFO to board: 3 notes

Private biopharmaceutical company CytoSen Therapeutics appointed Jason Wilson to the company’s board of directors.

Advertisement

Three notes:

1. Mr. Wilson has more than two decades of corporate finance and life science operations experience.

2. He is currently CFO of Reata Pharmaceuticals, where he leads multiple areas, including corporate strategy, finance, accounting, treasury, investor relations, human resources and IT.

3. Mr. Wilson previously served as vice president of finance and corporate controller at Caris Diagnostics and senior manager in Ernst & Young’s health-sciences group.

 

More articles on leadership and management:

CHI Health CEO: Hospital-owned drug company is perfect industry disruptor
Ousted California hospital board member resigns clinical privileges
4 tips for physicians who want to be good mentors

At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.

Register to Attend Webinar

Rethinking Safety and Security in the Healthcare Environment

Thursday, July 23
1:00 PM - 2:00 PM CDT

Presenters: Jon Share, AxonDan Snyder, Advocate HealthKeith Hunter, Wellstar

Advertisement

Next Up in Leadership & Management

Advertisement

Comments are closed.